-
My Account
In App
My Account
BSE Live
Dec 05, 16:01Prev. Close
744.90
Open Price
758.25
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 05, 15:45Prev. Close
745.30
Open Price
747.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
745.20 (8)
| Cash Flow of Supriya Lifescience (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
| 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 248.48 | 165.69 | 123.49 | 207.25 | |
| Net CashFlow From Operating Activities | 164.68 | 113.31 | 66.19 | 48.80 | |
| Net Cash Used In Investing Activities | -152.24 | -173.58 | -133.15 | -59.82 | |
| Net Cash Used From Financing Activities | -8.23 | -22.36 | -3.37 | 149.65 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 4.20 | -82.63 | -70.33 | 138.63 | |
| Cash And Cash Equivalents Begin of Year | 74.96 | 157.58 | 227.91 | 89.28 | |
| Cash And Cash Equivalents End Of Year | 79.15 | 74.96 | 157.58 | 227.91 |
28.11.2025
Buy Supriya Lifescience; target of Rs 1030: Choice Institutional Equities
18.11.2025
Accumulate Supriya Lifescience; target of Rs 850: Deven Choksey
13.11.2025
Supriya Lifesci Standalone September 2025 Net Sales at Rs 199.83 crore, up 20.31% Y-o-Y
12.11.2025
Buy Supriya Lifescience; target of Rs 1030: Choice Equity Broking
13.11.2025
Supriya Lifesci Standalone September 2025 Net Sales at Rs 199.83 crore, up 20.31% Y-o-Y
28.05.2025
Supriya Lifesci Standalone March 2025 Net Sales at Rs 184.11 crore, up 16.39% Y-o-Y
27.01.2025
Supriya Lifesci Standalone December 2024 Net Sales at Rs 185.65 crore, up 32.54% Y-o-Y
29.10.2024
Supriya Lifesci Standalone September 2024 Net Sales at Rs 166.10 crore, up 18.56% Y-o-Y
